1. Kanis J , McCloskey E , Harvey NC , Javaid MK , Borgstrom F. Broken Bones, Broken Lives: A roadmap to solve the fragility fracture crisis in the United Kingdom. http://share.iofbonehealth.org/EU-6-Material/Reports/IOF_report_UK.pdf: International Osteoporosis Foundation, 2018.
2. National Clinical Guideline Centre N. Osteoporosis: assessing the risk of fragility fracture: NICE clinical guideline 146. In: (NICE) NIfHaCE, editor. 2012.
3. NICE. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. In: Excellence NIfHaC, editor. NICE Technology Appraisal guidance 161. London: NICE; 2008.
4. NICE. Denosumab for the prevention of osteoporotic fractures in postmenopausal women. In: NICE, editor. London 2010.
5. Association Between Recurrent Fracture Risk and Implementation of Fracture Liaison Services in Four Swedish Hospitals: A Cohort Study